Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

NCT01351610 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia
Peripheral Artery Disease

Interventions

BIOLOGICAL: PTA + Infusion of MSC_Apceth
PROCEDURE: PTA

Sponsor

Apceth GmbH & Co. KG